Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on Nov. 5 reported a third-quarter loss of $50.1 million. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 27 cents. The results topped Wall Street expectations. The average estimate of analysts was for a loss of 30 cents per share. The company posted revenue of $14.7 million in the period, which did not meet Street … Continue reading Stocks in News: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Rite Aid Corporation (NYSE:RAD), SIGA Technologies, Inc. (NASDAQ:SIGA), VASCO Data Security International (NASDAQ:VDSI), GigOptix (NYSEMKT:GIG)